Pterostilbene restores autophagic activity in cisplatin-resistant OSCC cells by activating autophagy-related genes, including ATG5, ATG7, and Beclin-1, through modulation of the AKT pathway, leading to enhanced cancer cell death. This evidence concerns the gene AKT1 and cancer.